Skip to main content
logo
Aclaris Therapeutics, Inc. (ACRS)
NASDAQ: ACRS · Real-Time Price · USD
3.040
-0.010 (-0.33%)
Mar 3, 2026, 3:02 PM EST - Market open

Aclaris Therapeutics Revenue

In the year 2025, Aclaris Therapeutics had annual revenue of $7.83M, down -58.19%. Aclaris Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -85.94%.

Revenue (ttm)
$7.83M
Revenue Growth
-58.20%
P/S Ratio
47.23
Revenue / Employee
$107,205
Employees
73
Market Cap
366.61M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.83M-10.89M-58.19%
Dec 31, 202418.72M-12.53M-40.09%
Dec 31, 202331.25M1.50M5.03%
Dec 31, 202229.75M22.99M340.05%
Dec 31, 20216.76M279.00K4.30%
Dec 31, 20206.48M2.26M53.35%
Dec 31, 20194.23M-1.92M-31.28%
Dec 31, 20186.15M4.47M265.48%
Dec 31, 20171.68M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ACRS News

More News